A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
Clinical trial NCT06041061 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06041061
- Sponsor
- Sinocelltech Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-13
- Primary completion
- 2024-03-01
- Enrollment
- 18000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.